DAVITA INC. — Director's Dealing 2017

May 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA INC. (DVA)
CIK: 0000927066
Period of Report: 2017-05-15

Reporting Person: Rodriguez Javier (CEO-Kidney Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-15	Common Stock	A	1294	—	Acquired	99111	Direct
2017-05-15	Common Stock	S	1294	$66.2058	Disposed	97817	Direct

Footnotes

F1: Represents the weighted average sale price of $65.2058. The range of prices for the sale of these shares was $66.1300 - $66.2550 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.